CCB International supports the listing of 3D Medicines (1244.HK) in Hong Kong
2022-12-30
Being the Joint Bookrunner and Joint Lead Manager, CCB International supported the public listing of 3D Medicines Inc. on the Main Board of the Hong Kong Stock Exchange on December 15, 2022.